Items where authors include "Papa, S"
Article
Papa, S orcid.org/0000-0002-8369-6538, Bubici, C and Syn, W-K (2021) STARD1: a new rising StAR in cholesterol-mediated hepatocarcinogenesis. Hepatobiliary Surgery and Nutrition, 10 (6). pp. 910-912. ISSN 2304-3881
Lepore, A orcid.org/0000-0002-2037-673X, Choy, PM, Lee, NCW et al. (13 more authors) (2021) Phosphorylation and stabilization of PIN1 by JNK promote intrahepatic cholangiocarcinoma growth. Hepatology, 74 (5). pp. 2561-2579. ISSN 0270-9139
Arif, E, Wang, C, Swiderska-Syn, MK et al. (9 more authors) (2021) Targeting Myosin 1c Inhibits Murine Hepatic Fibrogenesis. American Journal of Physiology: Gastrointestinal and Liver Physiology. ISSN 0193-1857
Flati, V, Corsetti, G and Papa, S orcid.org/0000-0002-8369-6538 (2021) Editorial: The Dynamic Interplay Between Nutrition, Autophagy and Cell Metabolism. Frontiers in Cell and Developmental Biology, 9. 684049. ISSN 2296-634X
Bubici, C, Lepore, A orcid.org/0000-0002-2037-673X and Papa, S orcid.org/0000-0002-8369-6538 (2019) ASKing No More: The Emerging Role of Dual‐Specific Phosphatase 12 in the Regulation of Hepatic Lipid Metabolism. Hepatology, 70 (4). pp. 1091-1094. ISSN 0270-9139
Bubici, C and Papa, S orcid.org/0000-0002-8369-6538 (2019) The Warburg Effect Regulation Under Siege: the Intertwined Pathways in Health and Disease. Frontiers in Cell and Developmental Biology, 7. UNSP 80. ISSN 2296-634X
Papa, S orcid.org/0000-0002-8369-6538, Choy, PM and Bubici, C (2019) The ERK and JNK pathways in the regulation of metabolic reprogramming. Oncogene, 38 (13). pp. 2223-2240. ISSN 0950-9232
Lee, NCW, Carella, MA, Papa, S orcid.org/0000-0002-8369-6538 et al. (1 more author) (2018) High Expression of Glycolytic Genes in Cirrhosis Correlates With the Risk of Developing Liver Cancer. Frontiers in Cell and Developmental Biology, 6. 138. ISSN 2296-634X
Papa, S orcid.org/0000-0002-8369-6538 and Bubici, C (2018) Feeding the Hedgehog: A new meaning for JNK signalling in liver regeneration. Journal of Hepatology, 69 (3). pp. 572-574. ISSN 0168-8278
Manka, P, Coombes, JD, Boosman, R et al. (3 more authors) (2018) Thyroid hormone in the regulation of hepatocellular carcinoma and its microenvironment. Cancer Letters, 419. pp. 175-186. ISSN 0304-3835
Verzella, D, Bennett, J, Fischietti, M et al. (17 more authors) (2018) GADD45β Loss Ablates Innate Immunosuppression in Cancer. Cancer Research, 78 (5). pp. 1275-1292. ISSN 0008-5472
Papa, S orcid.org/0000-0002-8369-6538 and Bubici, C (2016) Linking apoptosis to cancer metabolism: Another missing piece of JuNK. Molecular & Cellular Oncology, 3 (2). e1103398. ISSN 2372-3556
Bubici, C and Papa, S orcid.org/0000-0002-8369-6538 (2015) Starving cancer cells of sugar could be the key to future treatment. The Conversation.
Iansante, V, Choy, PM, Fung, SW et al. (10 more authors) (2015) PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation. Nature Communications, 6. 7882. ISSN 2041-1723
Bubici, C and Papa, S orcid.org/0000-0002-8369-6538 (2014) JNK signalling in cancer: in need of new, smarter therapeutic targets. British Journal of Pharmacology, 171 (1). pp. 24-37. ISSN 0007-1188
Barbarulo, A, Iansante, V, Chaidos, A et al. (7 more authors) (2013) Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma. Oncogene, 32 (36). pp. 4231-4242. ISSN 0950-9232
Book Section
Lepore, A orcid.org/0000-0002-2037-673X, Kaci, FN, Bubici, C et al. (1 more author) (2023) An Integrated Methodology to Quantify the Glycolytic Stress in Plasma Cell Myeloma in Response to Cytotoxic Drugs. In: Papa, S and Bubici, C, (eds.) Metabolic Reprogramming: Methods and Protocols. Methods in Molecular Biology, 2675 . Springer , pp. 285-296. ISBN 9781071632468
Kaci, FN, Lepore, A orcid.org/0000-0002-2037-673X, Papa, S orcid.org/0000-0002-8369-6538 et al. (1 more author) (2023) Screening Kinase-Dependent Phosphorylation of Key Metabolic Reprogramming Regulators. In: Papa, S and Bubici, C, (eds.) Metabolic Reprogramming Methods and Protocols. Methods in Molecular Biology, 2675 . Springer , pp. 205-218. ISBN 978-1-0716-3246-8
Proceedings Paper
Papa, S orcid.org/0000-0002-8369-6538, Lee, N and Bubici, C (2018) Deciphering preventive and prognostic biomarkers of liver cancer. In: NCRI Cancer Conference abstracts. NCRI Cancer Conference 2018, 04-06 Nov 2018. NCRI .
Briones, MA, Coombes, JD, Mellone, M et al. (12 more authors) (2016) The role of osteopontin isoforms in cholangiocarcinoma. In: Hepatology. The 67th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2016, 11-15 Nov 2016, Massachusetts, United States. Wiley , 235A-235A.
Briones-Orta, MA, Coombes, JD, Mellone, M et al. (11 more authors) (2015) Osteopontin‐c isoform promotes a mesenchymal phenotype in human cholangiocarcinoma cells. In: Hepatology. 66th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2015, 13-17 Nov 2015, San Francisco, CA, USA. Wiley , 1171A-1171A.
Iansante, V, Choy, PM, Chokshi, S et al. (4 more authors) (2015) Addressing the interplay between apoptosis and glucose metabolism in liver cirrhosis and HCC. In: Gut. 2nd Digestive Disorders Federation Conference, 22-25 Jun 2015, London, UK. BMJ Publishing Group , A12-A12.
Choy, PM, Sufi, J, Glaser, S et al. (7 more authors) (2015) Inhibition of mapk signalling promotes cell cycle arrest and sensitises intrahepatic cholangiocarcinoma cells to chemotherapy. In: Gut. 2nd Digestive Disorders Federation Conference, 22-25 Jun 2015, London, UK. BMJ Publishing Group , A458-A458.
Iansante, V, Choy, PM, Chokshi, S et al. (4 more authors) (2015) Increased aerobic glycolysis is associated with poor outcome and suppression of apoptosis in human liver cirrhosis and HCC. In: Journal of Hepatology. The International Liver Congress 2015: 50th Annual meeting of the European Association for the Study of the Liver, 22-26 Apr 2015, Vienna, Austria. Elsevier , S427-S427.
Iansante, V, Choy, PM, Fung, SW et al. (8 more authors) (2014) Upregulation of a novel protein in HCC enhances cancer cell survival by suppressing specific apoptotic effectors. In: Journal of Hepatology. The International Liver Congress 2014 – 49th Annual meeting of the European Association for the Study of the Liver, 09-13 Apr 2014, London, UK. Elsevier , S89-S89.
Other
Papa, S orcid.org/0000-0002-8369-6538 and Bubici, C (2021) Bile duct cancer: existing leukaemia treatment could hold promise – mouse study. The Conversation.